United States

Top 538 largest US Companies in the Biotechnology industry by Market Cap

This is the list of the largest public listed companies in the Biotechnology industry from the United States by market capitalization with links to their reference stock.

United States Biotechnology Industry Analysis
Top US Companies United States Analysis
World Top Companies World Companies Analysis

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Top Biotechnology Companies from the United States as of Jul. 01, 2024

Download Excel

Rank Company Market Cap (USD) Country Sector Industry
181 Nkarta, Inc. $365.0 M United States US Healthcare US Biotechnology
182 Fate Therapeutics, Inc. $360.8 M United States US Healthcare US Biotechnology
183 Precigen, Inc. $358.4 M United States US Healthcare US Biotechnology
184 Anavex Life Sciences Corp. $354.6 M United States US Healthcare US Biotechnology
185 Silverback Therapeutics, Inc. $341.8 M United States US Healthcare US Biotechnology
186 Cabaletta Bio, Inc. $340.3 M United States US Healthcare US Biotechnology
187 Xeris Biopharma Holdings, Inc. $320.2 M United States US Healthcare US Biotechnology
188 Agenus Inc. $317.7 M United States US Healthcare US Biotechnology
189 Verrica Pharmaceuticals Inc. $317.1 M United States US Healthcare US Biotechnology
190 Cerus Corporation $314.3 M United States US Healthcare US Biotechnology
191 Vanda Pharmaceuticals Inc. $311.9 M United States US Healthcare US Biotechnology
192 C4 Therapeutics, Inc. $311.0 M United States US Healthcare US Biotechnology
193 Oyster Point Pharma, Inc. $299.9 M

(Dec. 1, 2022)

 United States US Healthcare US Biotechnology
194 XOMA Corporation $298.3 M United States US Healthcare US Biotechnology
195 Poseida Therapeutics, Inc. $293.5 M United States US Healthcare US Biotechnology
196 Foghorn Therapeutics Inc. $293.2 M United States US Healthcare US Biotechnology
197 Nautilus Biotechnology, Inc. $288.1 M United States US Healthcare US Biotechnology
198 Cerecor Inc. $285.0 M

(June 1, 2022)

 United States US Healthcare US Biotechnology
199 ALX Oncology Holdings Inc. $283.9 M United States US Healthcare US Biotechnology
200 Enanta Pharmaceuticals, Inc. $283.6 M United States US Healthcare US Biotechnology
201 Revance Therapeutics, Inc. $278.9 M United States US Healthcare US Biotechnology
202 Inozyme Pharma, Inc. $277.7 M United States US Healthcare US Biotechnology
203 Atea Pharmaceuticals, Inc. $273.7 M United States US Healthcare US Biotechnology
204 MacroGenics, Inc. $263.1 M United States US Healthcare US Biotechnology
205 MeiraGTx Holdings plc $258.5 M United States US Healthcare US Biotechnology
206 Zentalis Pharmaceuticals, Inc. $257.1 M United States US Healthcare US Biotechnology
207 Chiasma, Inc. $253.0 M

(July 1, 2021)

 United States US Healthcare US Biotechnology
208 Black Diamond Therapeutics, Inc. $251.5 M United States US Healthcare US Biotechnology
209 Epizyme, Inc. $247.5 M

(Aug. 1, 2022)

 United States US Healthcare US Biotechnology
210 Sutro Biopharma, Inc. $245.8 M United States US Healthcare US Biotechnology

Top Biotechnology Companies from the United States as of Jul. 01, 2024

181. Nkarta, Inc.

Company Profile: Nkarta, Inc.
Market Cap (USD): $365.0 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

182. Fate Therapeutics, Inc.

Company Profile: Fate Therapeutics, Inc.
Market Cap (USD): $360.8 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

183. Precigen, Inc.

Company Profile: Precigen, Inc.
Market Cap (USD): $358.4 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

184. Anavex Life Sciences Corp.

Company Profile: Anavex Life Sciences Corp.
Market Cap (USD): $354.6 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

185. Silverback Therapeutics, Inc.

Company Profile: Silverback Therapeutics, Inc.
Market Cap (USD): $341.8 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

186. Cabaletta Bio, Inc.

Company Profile: Cabaletta Bio, Inc.
Market Cap (USD): $340.3 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

187. Xeris Biopharma Holdings, Inc.

Company Profile: Xeris Biopharma Holdings, Inc.
Market Cap (USD): $320.2 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

188. Agenus Inc.

Company Profile: Agenus Inc.
Market Cap (USD): $317.7 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

189. Verrica Pharmaceuticals Inc.

Company Profile: Verrica Pharmaceuticals Inc.
Market Cap (USD): $317.1 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

190. Cerus Corporation

Company Profile: Cerus Corporation
Market Cap (USD): $314.3 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

191. Vanda Pharmaceuticals Inc.

Company Profile: Vanda Pharmaceuticals Inc.
Market Cap (USD): $311.9 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

192. C4 Therapeutics, Inc.

Company Profile: C4 Therapeutics, Inc.
Market Cap (USD): $311.0 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

193. Oyster Point Pharma, Inc.

Company Profile: Oyster Point Pharma, Inc.
Market Cap (USD): $299.9 M (Dec. 1, 2022)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

194. XOMA Corporation

Company Profile: XOMA Corporation
Market Cap (USD): $298.3 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

195. Poseida Therapeutics, Inc.

Company Profile: Poseida Therapeutics, Inc.
Market Cap (USD): $293.5 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

196. Foghorn Therapeutics Inc.

Company Profile: Foghorn Therapeutics Inc.
Market Cap (USD): $293.2 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

197. Nautilus Biotechnology, Inc.

Company Profile: Nautilus Biotechnology, Inc.
Market Cap (USD): $288.1 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

198. Cerecor Inc.

Company Profile: Cerecor Inc.
Market Cap (USD): $285.0 M (June 1, 2022)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

199. ALX Oncology Holdings Inc.

Company Profile: ALX Oncology Holdings Inc.
Market Cap (USD): $283.9 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

200. Enanta Pharmaceuticals, Inc.

Company Profile: Enanta Pharmaceuticals, Inc.
Market Cap (USD): $283.6 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

201. Revance Therapeutics, Inc.

Company Profile: Revance Therapeutics, Inc.
Market Cap (USD): $278.9 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

202. Inozyme Pharma, Inc.

Company Profile: Inozyme Pharma, Inc.
Market Cap (USD): $277.7 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

203. Atea Pharmaceuticals, Inc.

Company Profile: Atea Pharmaceuticals, Inc.
Market Cap (USD): $273.7 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

204. MacroGenics, Inc.

Company Profile: MacroGenics, Inc.
Market Cap (USD): $263.1 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

205. MeiraGTx Holdings plc

Company Profile: MeiraGTx Holdings plc
Market Cap (USD): $258.5 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

206. Zentalis Pharmaceuticals, Inc.

Company Profile: Zentalis Pharmaceuticals, Inc.
Market Cap (USD): $257.1 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

207. Chiasma, Inc.

Company Profile: Chiasma, Inc.
Market Cap (USD): $253.0 M (July 1, 2021)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

208. Black Diamond Therapeutics, Inc.

Company Profile: Black Diamond Therapeutics, Inc.
Market Cap (USD): $251.5 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

209. Epizyme, Inc.

Company Profile: Epizyme, Inc.
Market Cap (USD): $247.5 M (Aug. 1, 2022)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

210. Sutro Biopharma, Inc.

Company Profile: Sutro Biopharma, Inc.
Market Cap (USD): $245.8 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

Top 1-year algo backtest: +265.99% - Try Disfold DeepFinance for FREE now!

Stay in touch